These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33081136)

  • 1. Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1.
    Zafar S; Jabeen I
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
    Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
    Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitors.
    Zafar S; Jabeen I
    PeerJ; 2019; 7():e6283. PubMed ID: 30723616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of GABA reuptake inhibition.
    Motiwala Z; Aduri NG; Shaye H; Han GW; Lam JH; Katritch V; Cherezov V; Gati C
    Nature; 2022 Jun; 606(7915):820-826. PubMed ID: 35676483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.
    Nowaczyk A; Fijałkowski Ł; Kowalska M; Podkowa A; Sałat K
    ACS Chem Neurosci; 2019 Jan; 10(1):337-347. PubMed ID: 30222312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and Simulation of
    Zafar S; Nguyen ME; Muthyala R; Jabeen I; Sham YY
    Comput Struct Biotechnol J; 2019; 17():61-69. PubMed ID: 30619541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).
    Jurik A; Zdrazil B; Holy M; Stockner T; Sitte HH; Ecker GF
    J Med Chem; 2015 Mar; 58(5):2149-58. PubMed ID: 25679268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for substrate recognition and transport of human GABA transporter GAT1.
    Zhu A; Huang J; Kong F; Tan J; Lei J; Yuan Y; Yan C
    Nat Struct Mol Biol; 2023 Jul; 30(7):1012-1022. PubMed ID: 37400655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A steered molecular dynamics study of binding and translocation processes in the GABA transporter.
    Skovstrup S; David L; Taboureau O; Jørgensen FS
    PLoS One; 2012; 7(6):e39360. PubMed ID: 22737235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modelling of the GABA transporter and analysis of tiagabine binding.
    Skovstrup S; Taboureau O; Bräuner-Osborne H; Jørgensen FS
    ChemMedChem; 2010 Jul; 5(7):986-1000. PubMed ID: 20491137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA transport goes structural.
    Kanner BI; Dayan-Alon O
    Trends Pharmacol Sci; 2023 Jan; 44(1):4-6. PubMed ID: 35985875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.
    Nowaczyk A; Fijałkowski Ł; Zaręba P; Sałat K
    J Mol Graph Model; 2018 Oct; 85():171-181. PubMed ID: 30219588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major human gamma-aminobutyrate transporter: in silico prediction of substrate efficacy.
    Palló A; Bencsura A; Héja L; Beke T; Perczel A; Kardos J; Simon A
    Biochem Biophys Res Commun; 2007 Dec; 364(4):952-8. PubMed ID: 17967412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity relationship of selective GABA uptake inhibitors.
    Vogensen SB; Jørgensen L; Madsen KK; Jurik A; Borkar N; Rosatelli E; Nielsen B; Ecker GF; Schousboe A; Clausen RP
    Bioorg Med Chem; 2015 May; 23(10):2480-8. PubMed ID: 25882526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Different Binding Modes for Tiagabine within the GAT-1 Transporter.
    Łątka K; Bajda M
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine does not attenuate alcohol-induced activation of the human reward system.
    Fehr C; Hohmann N; Gründer G; Dielentheis TF; Buchholz HG; Chechko N; Yakushev I; Landvogt C; Bartenstein P; Urban R; Schreckenberger M
    Psychopharmacology (Berl); 2007 May; 191(4):975-83. PubMed ID: 17265078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion binding and permeation at the GABA transporter GAT1.
    Mager S; Kleinberger-Doron N; Keshet GI; Davidson N; Kanner BI; Lester HA
    J Neurosci; 1996 Sep; 16(17):5405-14. PubMed ID: 8757253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.